| 1 |
Wong A, Barrero Guevara LA, Goult E, Briga M, Kramer SC, Kovacevic A, Opatowski L, Domenech de Cellès M. The interactions of SARS-CoV-2 with cocirculating pathogens: Epidemiological implications and current knowledge gaps. PLoS Pathog 2023;19:e1011167. [PMID: 36888684 DOI: 10.1371/journal.ppat.1011167] [Reference Citation Analysis]
|
| 2 |
Wang L, Peng HY, Pham A, Villazana E, Ballard DJ, Das JK, Kumar A, Xiong X, Song J. T Cell Response to SARS-CoV-2 Coinfection and Comorbidities. Pathogens 2023;12. [PMID: 36839596 DOI: 10.3390/pathogens12020321] [Reference Citation Analysis]
|
| 3 |
Zsichla L, Müller V. Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors. Viruses 2023;15. [PMID: 36680215 DOI: 10.3390/v15010175] [Reference Citation Analysis]
|
| 4 |
Yau E, Yang L, Chen Y, Umstead TM, Atkins H, Katz ZE, Yewdell JW, Gandhi CK, Halstead ES, Chroneos ZC. Surfactant protein A alters endosomal trafficking of influenza A virus in macrophages. Front Immunol 2023;14:919800. [PMID: 36960051 DOI: 10.3389/fimmu.2023.919800] [Reference Citation Analysis]
|
| 5 |
Dee K, Schultz V, Haney J, Bissett LA, Magill C, Murcia PR. Influenza A and respiratory syncytial virus trigger a cellular response that blocks severe acute respiratory syndrome virus 2 infection in the respiratory tract. J Infect Dis 2022:jiac494. [PMID: 36550077 DOI: 10.1093/infdis/jiac494] [Reference Citation Analysis]
|
| 6 |
Vilas Boas de Melo C, Peters F, van Dijken H, Lenz S, van de Ven K, Wijsman L, Gomersbach A, Schouten T, van Kasteren PB, van den Brand J, de Jonge J. Influenza Infection in Ferrets with SARS-CoV-2 Infection History. Microbiol Spectr 2022;10:e0138622. [PMID: 36301107 DOI: 10.1128/spectrum.01386-22] [Reference Citation Analysis]
|
| 7 |
Domovitz T, Ayoub S, Werbner M, Alter J, Izhaki Tavor L, Yahalom-Ronen Y, Tikhonov E, Meirson T, Maman Y, Paran N, Israely T, Dessau M, Gal-Tanamy M. HCV Infection Increases the Expression of ACE2 Receptor, Leading to Enhanced Entry of Both HCV and SARS-CoV-2 into Hepatocytes and a Coinfection State. Microbiol Spectr 2022;10:e0115022. [PMID: 36314945 DOI: 10.1128/spectrum.01150-22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 8 |
Lei H, Yang L, Yang M, Tang J, Yang J, Tan M, Yang S, Wang D, Shu Y. Quantifying the rebound of influenza epidemics after relaxing nonpharmaceutical interventions during the coronavirus disease 2019 pandemic in China.. [DOI: 10.1101/2022.12.18.22283627] [Reference Citation Analysis]
|
| 9 |
Fahim M, Roshdy WH, Deghedy O, Kamel R, Naguib A, Showky S, Elguindy N, Abdel Fattah M, Afifi S, Mohsen A, Kandeel A, Abdelghaffar K. Epidemiology, Disease Severity and Outcome of Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza Viruses Coinfection Seen at Egypt Integrated Acute Respiratory Infections Surveillance, 2020-2022. Can J Infect Dis Med Microbiol 2022;2022:7497500. [PMID: 36437892 DOI: 10.1155/2022/7497500] [Reference Citation Analysis]
|
| 10 |
Tang CY, Boftsi M, Staudt L, McElroy JA, Li T, Duong S, Ohler A, Ritter D, Hammer R, Hang J, Wan XF. SARS-CoV-2 and influenza co-infection: A cross-sectional study in central Missouri during the 2021-2022 influenza season. Virology 2022;576:105-10. [PMID: 36206606 DOI: 10.1016/j.virol.2022.09.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 11 |
Zafarnejad R, Griffin PM, Ventresca M. A Joint Compartmental Model for The Co-infection of SARS-CoV-2 and Influenza.. [DOI: 10.1101/2022.08.26.22279281] [Reference Citation Analysis]
|
| 12 |
Weidmann MD, Berry GJ, Green DA, Wu F. Prevalence and clinical disease severity of respiratory co-infections during the COVID-19 pandemic. Advances in Molecular Pathology 2022. [DOI: 10.1016/j.yamp.2022.07.003] [Reference Citation Analysis]
|
| 13 |
Ye Q, Wu M, Zhou C, Lu X, Huang B, Zhang N, Zhao H, Chi H, Zhang X, Ling D, Zhang RR, Li Z, Luo D, Huang YJ, Qiu HY, Song H, Tan W, Xu K, Ying B, Qin CF. Rational development of a combined mRNA vaccine against COVID-19 and influenza. NPJ Vaccines 2022;7:84. [PMID: 35882870 DOI: 10.1038/s41541-022-00478-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Oishi K, Horiuchi S, Minkoff JM, tenOever BR, Heise MT. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection. J Virol. [DOI: 10.1128/jvi.00765-22] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 15 |
Seo SU, Seong BL. Prospects on Repurposing a Live Attenuated Vaccine for the Control of Unrelated Infections. Front Immunol 2022;13:877845. [PMID: 35651619 DOI: 10.3389/fimmu.2022.877845] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Stölting H, Baillon L, Frise R, Bonner K, Hewitt RJ, Molyneaux PL, Gore ML, Barclay WS, Saglani S, Lloyd CM; Breathing Together Consortium. Distinct airway epithelial immune responses after infection with SARS-CoV-2 compared to H1N1. Mucosal Immunol 2022;15:952-63. [PMID: 35840680 DOI: 10.1038/s41385-022-00545-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 17 |
Bar-On L, Aftalion M, Makdasi E, Gur D, Alcalay R, Cohen H, Beth-Din A, Rosenfeld R, Achdout H, Bar-Haim E, Falach R, Chitlaru T, Cohen O. Prolonged Protective Immunity Induced by Mild SARS-CoV-2 Infection of K18-hACE2 Mice. Vaccines (Basel) 2022;10:613. [PMID: 35455362 DOI: 10.3390/vaccines10040613] [Reference Citation Analysis]
|
| 18 |
de Melo CVB, Peters F, van Dijken H, Lenz S, van de Ven K, Wijsman L, Gommersbach A, Schouten T, van Kasteren PB, Judith VDB, de Jonge J. Influenza infection in ferrets with SARS-CoV-2 infection history.. [DOI: 10.1101/2022.03.22.485425] [Reference Citation Analysis]
|
| 19 |
Pinky L, Dobrovolny HM. Epidemiological Consequences of Viral Interference: A Mathematical Modeling Study of Two Interacting Viruses. Front Microbiol 2022;13:830423. [DOI: 10.3389/fmicb.2022.830423] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 20 |
Mukae H. 5. Clinical Practice of Respiratory Infectious Diseases in the "with/after COVID-19 Era". J Jpn Soc Intern Med 2022;111:578-584. [DOI: 10.2169/naika.111.578] [Reference Citation Analysis]
|
| 21 |
Fage C, Hénaut M, Carbonneau J, Piret J, Boivin G. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells. Viruses 2022;14:395. [DOI: 10.3390/v14020395] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
|
| 22 |
De Sanctis JB, Garmendia JV, Hajdúch M. Overview of Memory NK Cells in Viral Infections: Possible Role in SARS-CoV-2 Infection. Immuno 2022;2:52-67. [DOI: 10.3390/immuno2010005] [Reference Citation Analysis]
|
| 23 |
Cox G, Gonzalez AJ, Ijezie EC, Rodriguez A, Miller CR, Van Leuven JT, Miura TA. Priming With Rhinovirus Protects Mice Against a Lethal Pulmonary Coronavirus Infection. Front Immunol 2022;13:886611. [PMID: 35711419 DOI: 10.3389/fimmu.2022.886611] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
